Tag Archive | "pfizer inc"

Pfizer Makes Vet Business Change

Pfizer Makes Vet Business Change

Pfizer (NYSE:PFE) has appointed a new head to lead its Veterinary Business Solutions.

Pfizer Makes Vet Business Change

According to an announcement made by the company, the Animal Health unit of Pfizer (NYSE:PFE) has appointed Steve Sornsen as the new senior director for its Veterinary Business Solutions unit.

In his new role, he will be responsible for leading and implementing efforts for the U.S. Pork Business Unit to help expand veterinary customer relationships.

Gloria Basse, group director, U.S. Pork Business Unit at Pfizer (NYSE:PFE) said, “Steve has always been a great source of leadership and knowledge. With this exciting new role, he will utilize this expertise to develop a wide array of strategic solutions for our veterinary customers. Our goal is to be the complete solutions provider for veterinarians, and Steve will help us achieve this goal.”

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 21.33.

Pfizer Makes Vet Business Change
Price History
Last Price: 21.33
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 21.35
6 Month Price Change %: 14.2%
12 Month Price Change %: 10.8%

Posted in PharmaComments (0)

Pfizer (NYSE:PFE) Selling Animal Health Unit

Pfizer (NYSE:PFE) Selling Animal Health Unit

Pfizer (NYSE:PFE) has decided to sell its animal health business unit in India.

Pfizer (NYSE:PFE) Selling Animal Health Unit

The Indian unit of drug maker Pfizer (NYSE:PFE) said that its board has approved the sale of its animal health division to a wholly owned unit for about $90 million.

Pfizer (NYSE:PFE) said in a filing, “The Board of Directors of the company, at its meeting held on February 6, 2012, has approved the sale of its animal health division by way of a slump sale to its wholly-owned subsidiary in consideration of approximately Rs 440 crore ($90 million).”

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 21.05.

Pfizer (NYSE:PFE) Selling Animal Health Unit
Price History
Last Price: 21.05
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 21.1
6 Month Price Change %: 25.8%
12 Month Price Change %: 8.6%

Posted in PharmaComments (0)

Pfizer (NYSE:PFE) Makes Foundation Support Pledge

Pfizer (NYSE:PFE) Makes Foundation Support Pledge

Pfizer (NYSE:PFE) has partnered with customers to contribute to the FFA, AABP and AAEP Foundations in 2012.

Pfizer (NYSE:PFE) Makes Foundation Support Pledge

The animal Health unit of the US based drug maker giant Pfizer (NYSE:PFE) has announced the return of the FFA and American Association of Bovine Practitioners (AABP) Foundation Support Program and the addition of the American Association of Equine Practitioners (AAEP) Foundation Support Program.

Julian Garcia, group director, U.S. Cattle and Equine Marketing, Pfizer (NYSE:PFE) Animal Health said, “Our support to all three organizations helps honor the assistance and encouragement many of our team members at Pfizer (NYSE:PFE) Animal Health received when they were students. Many of us at Pfizer (NYSE:PFE) Animal Health have been directly involved with these organizations, and now it’s our chance to work with our veterinary clinic, dealer and distributor partners to give back. In turn, we are supporting the next generation of our industry.”

Pfizer Inc. (NYSE:PFE) company shares are currently standing at 21.31.

Pfizer (NYSE:PFE) Makes Foundation Support Pledge
Price History
Last Price: 21.31
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 20.95
6 Month Price Change %: 18.0%
12 Month Price Change %: 17.5%

Posted in PharmaComments (0)

Pfizer (NYSE:PFE) Recalls Birth Control Pills Over Error

Pfizer (NYSE:PFE) Recalls Birth Control Pills Over Error

Pfizer (NYSE:PFE) has recalled 28 lots of birth control pills due to a packaging error.

Pfizer (NYSE:PFE) Recalls Birth Control Pills Over Error

The pharmaceutical giant Pfizer (NYSE:PFE) is recalling 1 million packets of birth control pills after uncovering a packaging error that could leave women with an inadequate dose of the hormone-based drugs and raise the risk that they may get pregnant accidentally.

Grace Ann Arnold, a Pfizer (NYSE:PFE) spokeswoman said, “The company recalled 14 lots of Lo/Ovral-28 tablets and 14 lots of a generic version of the medicine. The problem was caused by both mechanical and visual inspection failures on the packaging line.”

Pfizer Inc. (NYSE:PFE) company shares are currently standing at 21.40.

Pfizer (NYSE:PFE) Recalls Birth Control Pills Over Error
Price History
Last Price: 21.40
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 20.91
6 Month Price Change %: 13.5%
12 Month Price Change %: 18.9%

Posted in PharmaComments (0)

Pfizer (NYSE:PFE) Donating To Canada Hospital

Pfizer (NYSE:PFE) Donating To Canada Hospital

Pfizer (NYSE:PFE) has awarded a donation for Windsor Regional Hospital in Canada.

Pfizer (NYSE:PFE) Donating To Canada Hospital

The US based drug maker giant Pfizer (NYSE:PFE) has provided a $30,000 donation for Windsor Regional Hospital in Canada that will help establish a clinic to house the Wellness Program for Extended Psychosis.

Sarah Mitton, Pfizer (NYSE:PFE) brand manager said, “Pfizer (NYSE:PFE)’s mission statement is really that it takes more than medication to be truly healthy. This is another example how partnering with local hospitals is really furthering benefit to patients in this area.”

Pfizer Inc. (NYSE:PFE) shares are currently standing at 21.66.

Pfizer (NYSE:PFE) Donating To Canada Hospital
Price History
Last Price: 21.66
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 20.72
6 Month Price Change %: 9.6%
12 Month Price Change %: 18.3%

Posted in PhilanthropyComments (0)

Pfizer (NYSE:PFE) To Begin Nigeria Project

Pfizer (NYSE:PFE) To Begin Nigeria Project

Pfizer (NYSE:PFE) has commissioned an e-pharmacy project at the Lagos University in Nigeria.

Pfizer (NYSE:PFE) To Begin Nigeria Project

The US Based pharmaceutical giant Pfizer (NYSE:PFE) has commissioned an e-pharmacy pilot project at the Lagos University Teaching Hospital(LUTH), Idi-Araba, aimed at creating a pool of credible and realizable data that can be used in a globally accepted research publication.

Dr. Enrico Liggeri, Pfizer (NYSE:PFE) Country Manager, Nigeria said, “Nigeria was selected as the target country for the e-pharmacy pilot due to the concentration of the largest high-risk patient populations as well as its complex and overstretched healthcare system. Once this pilot project is fully in operation, the company is prepared to expand to other units of the hospital and even other institutions in Nigeria and beyond.”

Pfizer Inc. (NYSE:PFE) stocks were at 21.6 at the end of the last day’s trading. There’s been a 22.6% change in the stock price over the past 3 months.

Pfizer (NYSE:PFE) To Begin Nigeria Project
Pfizer Inc. (NYSE:PFE) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 1.32
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.22
Zack’s Rank: 1 out of 14 in the industry

Posted in PharmaComments (0)

Pfizer (NYSE:PFE) Completes Pharma Buy

Pfizer (NYSE:PFE) Completes Pharma Buy

Pfizer (NYSE:PFE) has completed the acquisition of Excaliard Pharmaceuticals.

Pfizer (NYSE:PFE) Completes Pharma Buy

According to an announcement made by the drug maker giant Pfizer (NYSE:PFE), it has completely acquired privately owned biopharmaceutical company Excaliard Pharmaceuticals, which is focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.

Pfizer (NYSE:PFE) said in a statement, “At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals.”

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 20.23.

Pfizer (NYSE:PFE) Completes Pharma Buy
Price History
Last Price: 20.23
52 Week Low / High: 16.59 / 21.45
50 Day Moving Average: 19.05
6 Month Price Change %: -4.3%
12 Month Price Change %: 18.7%

Posted in PharmaComments (0)

Pfizer (NYSE:PFE) Buys Health Company

Pfizer (NYSE:PFE) Buys Health Company

Pfizer (NYSE:PFE) has completed the acquisition of Ferrosan Consumer Health’s business.

Pfizer (NYSE:PFE) Buys Health Company

According to an announcement made by the company, it has completed its previously announced acquisition of Ferrosan Consumer Health’s business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited.

Paul Sturman, President, Pfizer (NYSE:PFE) Consumer Healthcare said, “Today, we have taken an important step by adding leading brands to our existing portfolio as well as enhancing our presence in established and emerging markets such as the Nordic countries, Russia and Ukraine. Through this acquisition, we’ll have the opportunity to provide a broader portfolio of highly trusted and differentiated products to consumers.”

Pfizer Inc. (NYSE:PFE) stocks are currently standing at 20.03.

Pfizer (NYSE:PFE) Buys Health Company
Price History
Last Price: 20.03
52 Week Low / High: 16.59 / 21.45
50 Day Moving Average: 18.87
6 Month Price Change %: -9.6%
12 Month Price Change %: 17.2%

Posted in HealthComments (0)

Failed to get content from 'http://www.stocksandshares.tv/feed'
.
.